“…Metabolic evaluation of spinal cord pathologies using 18 F-FDG PET has been performed for more than 25 years, especially in cases of neoplastic diseases 8,16,24,26,27,29,32,40 but also in a variety of cases involving benign inflammatory intraspinal lesions such as infections, 17 tophaceous gout, 33 and neurosarcoidosis. 10,31 In all of these space-occupying and compressive lesions, 18 F-FDG PET has been used to differentiate between benign and malignant pathologies or to monitor biological activity.…”